108 related articles for article (PubMed ID: 26979247)
1. Secondary bone marrow malignancies after adjuvant chemotherapy for breast cancer: a report of 2 cases and a review of the literature.
Rossi D; Sarti D; Malerba L; Tommasoni S; Visani G; Martignetti A; Fiorentini G
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26979247
[TBL] [Abstract][Full Text] [Related]
2. Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.
Wolff AC; Blackford AL; Visvanathan K; Rugo HS; Moy B; Goldstein LJ; Stockerl-Goldstein K; Neumayer L; Langbaum TS; Theriault RL; Hughes ME; Weeks JC; Karp JE
J Clin Oncol; 2015 Feb; 33(4):340-8. PubMed ID: 25534386
[TBL] [Abstract][Full Text] [Related]
3. Primary breast lymphoma: case reports and review of the literature.
Sanguinetti A; Ragusa M; Lucchini R; Monacelli M; Calzolari F; Misso C; Avenia N
G Chir; 2008 May; 29(5):230-2. PubMed ID: 18507958
[TBL] [Abstract][Full Text] [Related]
4. Three patients with multiple myeloma developing secondary lymphoblastic leukemia: case reports and review of the literature.
Junxun L; Junru L; Meilan C; Chujia L; Shaoqian C; Jieyu Z; Zhuangjian Y; Fan Z; Juan O; Jing C; Juan L
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26166219
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer and synchronous multiple myeloma as a diagnostic challenge: Case report and review of literature.
Sokołowski M; Mazur G; Butrym A
Curr Probl Cancer; 2018; 42(2):231-234. PubMed ID: 29241676
[TBL] [Abstract][Full Text] [Related]
6. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
7. [High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer].
Willems L; Suarez F; Messas E; Baubion N; Decaudin D; Fourquet A; Ghez D; Delarue R; Hermine O; Buzyn A; Varet B; Rubio MT
Bull Cancer; 2010 Feb; 97(2):245-54. PubMed ID: 19819776
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
[TBL] [Abstract][Full Text] [Related]
9. Secondary hematological malignancies after breast cancer chemotherapy.
Park MJ; Park YH; Ahn HJ; Choi W; Paik KH; Kim JM; Chang YH; Ryoo BY; Yang SH
Leuk Lymphoma; 2005 Aug; 46(8):1183-8. PubMed ID: 16085560
[TBL] [Abstract][Full Text] [Related]
10. Risks of second malignancies after breast cancer treatment: Long-term results.
Bazire L; De Rycke Y; Asselain B; Fourquet A; Kirova YM
Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.
Müller V; Stahmann N; Riethdorf S; Rau T; Zabel T; Goetz A; Jänicke F; Pantel K
Clin Cancer Res; 2005 May; 11(10):3678-85. PubMed ID: 15897564
[TBL] [Abstract][Full Text] [Related]
12. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
Diamandidou E; Buzdar AU; Smith TL; Frye D; Witjaksono M; Hortobagyi GN
J Clin Oncol; 1996 Oct; 14(10):2722-30. PubMed ID: 8874333
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
[TBL] [Abstract][Full Text] [Related]
14. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.
Fisher B; Rockette H; Fisher ER; Wickerham DL; Redmond C; Brown A
J Clin Oncol; 1985 Dec; 3(12):1640-58. PubMed ID: 3906049
[TBL] [Abstract][Full Text] [Related]
15. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
[TBL] [Abstract][Full Text] [Related]
16. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
17. Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: do it or not?
Ragaz J; Spinelli JJ
Int J Cancer; 2000 Aug; 87(3):423-6. PubMed ID: 10897049
[No Abstract] [Full Text] [Related]
18. Ipsilateral breast carcinoma following treatment for primary breast lymphoma.
Geffen DB; Cagnano E; Tokar M; Ariad S; Koretz M
Onkologie; 2007 Mar; 30(3):134-6. PubMed ID: 17341900
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study.
Chaplain G; Milan C; Sgro C; Carli PM; Bonithon-Kopp C
J Clin Oncol; 2000 Aug; 18(15):2836-42. PubMed ID: 10920131
[TBL] [Abstract][Full Text] [Related]
20. Late effects of adjuvant therapy for breast cancer.
Shapiro CL; Recht A
J Natl Cancer Inst Monogr; 1994; (16):101-12. PubMed ID: 7999452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
